STAT3 induces anoikis resistance, promotes cell invasion and metastatic potential in pancreatic cancer cells

Carcinogenesis

Volumn 36, Issue 1, 2015, Pages 142-150

  Fofaria, Neel M ^a   Srivastava, Sanjay K ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; INTERLEUKIN 6; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PIPLARTINE; STAT3 PROTEIN; SULFORHODAMINE B; UNCLASSIFIED DRUG; SMALL INTERFERING RNA; STAT3 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOIKIS; ARTICLE; ASPC-1 CELL LINE; CELL CULTURE; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CELL VIABILITY; COLO 357 CELL LINE; CONTROLLED STUDY; DENSITOMETRY; GENE KNOCKDOWN; GENE OVEREXPRESSION; GENE SILENCING; HPAC CELL LINE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MOUSE; NONHUMAN; PANC-1 CELL LINE; PANCREATIC CANCER CELL LINE; PHOSPHORYLATION; SENSITIZATION; TRANSIENT TRANSFECTION; TRANSWELL ASSAY; WESTERN BLOTTING; WOUND HEALING ASSAY; XENOGRAFT; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; DRUG SCREENING; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; LUNG TUMOR; METABOLISM; NONOBESE DIABETIC MOUSE; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; SCID MOUSE; SECONDARY; TUMOR CELL CULTURE; TUMOR INVASION;

ANIMALS; ANOIKIS; APOPTOSIS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PHOSPHORYLATION; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85003052492     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu233     Document Type: Article

References (44)

1. Gilmore,A.P. (2005) Anoikis. Cell Death Differ., 12 (suppl. 2), 1473–1477.
2. Grossmann,J. (2002) Molecular mechanisms of “detachment-induced apoptosis–Anoikis”. Apoptosis, 7, 247–260.
3. Frisch,S.M. et al. (2001) Anoikis mechanisms. Curr. Opin. Cell Biol., 13, 555–562.
4. Simpson,C.D. et al. (2008) Anoikis resistance and tumor metastasis. Cancer Lett., 272, 177–185.
5. Coates,J.M. et al. (2010) Cancer therapy beyond apoptosis: autophagy and anoikis as mechanisms of cell death. J. Surg. Res., 164, 301–308.
6. Ihle,J.N. (1996) STATs: signal transducers and activators of transcription. Cell, 84, 331–334.
7. Darnell,J.E. Jr. (1997) STATs and gene regulation. Science, 277, 1630–1635.
8. Horvath,C.M. et al. (1997) The state of the STATs: recent developments in the study of signal transduction to the nucleus. Curr. Opin. Cell Biol., 9, 233–239.
9. Duncan,S.A. et al. (1997) STAT signaling is active during early mammalian development. Dev. Dyn., 208, 190–198.
10. Bromberg,J.F. et al. (1999) Stat3 as an oncogene. Cell, 98, 295–303.
11. Brivanlou,A.H. et al. (2002) Signal transduction and the control of gene expression. Science, 295, 813–818.
12. Benekli,M. et al. (2003) Signal transducer and activator of transcription proteins in leukemias. Blood, 101, 2940–2954.
13. Germain,D. et al. (2007) Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clin. Cancer Res., 13, 5665–5669.
14. Huang,M. et al. (2000) Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Gynecol. Oncol., 79, 67–73.
15. Bowman,T. et al. (2000) STATs in oncogenesis. Oncogene, 19, 2474–2488.
16. Coffer,P.J. et al. (2000) The role of STATs in myeloid differentiation and leukemia. Oncogene, 19, 2511–2522.
17. Song,J.I. et al. (2000) STAT signaling in head and neck cancer. Oncogene, 19, 2489–2495.
18. Niu,G. et al. (2002) Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Oncogene, 21, 7001–7010.
19. Levy,D.E. et al. (2002) Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol., 3, 651–662.
20. Darnell,J.E. Jr. (2002) Transcription factors as targets for cancer therapy. Nat. Rev. Cancer, 2, 740–749.
21. Darnell,J.E. (2005) Validating Stat3 in cancer therapy. Nat. Med., 11, 595–596.
22. Epling-Burnette,P.K. et al. (2001) Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J. Clin. Invest., 107, 351–362.
23. Gritsko,T. et al. (2006) Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin. Cancer Res., 12, 11–19.
24. Jemal,A. et al. (2010) Cancer statistics, 2010. CA. Cancer J. Clin., 60, 277–300.
25. Li,D. et al. (2004) Pancreatic cancer. Lancet, 363, 1049–1057.
26. Borja-Cacho,D. et al. (2008) Molecular targeted therapies for pancreatic cancer. Am. J. Surg., 196, 430–441.
27. Besmer,D.M. et al. (2011) Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis. Cancer Res., 71, 4432–4442.
28. Pramanik,K.C. et al. (2012) Apoptosis signal-regulating kinase 1-thiore-doxin complex dissociation by capsaicin causes pancreatic tumor growth suppressionbyinducingapoptosis.Antioxid.RedoxSignal.,17,1417–1432.
29. Boreddy,S.R. et al. (2013) Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic model. Oncogene, 32, 3980–3991.
30. Gupta,P. et al. (2013) Metastasis of breast tumor cells to brain is suppressed by phenethyl isothiocyanate in a novel in vivo metastasis model. PLoS One, 8, e67278.
31. Boreddy,S.R. et al. (2011) Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-α/VEGF/RhoGTPases: pivotal role of STAT-3. PLoS One, 6, e25799.
32. Kandala,P.K. et al. (2012) Diindolylmethane-mediated Gli1 protein suppression induces anoikis in ovarian cancer cells in vitro and blocks tumor formation ability in vivo. J. Biol. Chem., 287, 28745–28754.
33. Kandala,P.K. et al. (2012) Blocking epidermal growth factor receptor activation by 3,3’-diindolylmethane suppresses ovarian tumor growth in vitro and in vivo. J. Pharmacol. Exp. Ther., 341, 24–32.
34. Sahu,R.P. et al. (2009) The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate. J. Natl. Cancer Inst., 101, 176–193.
35. Gupta,P. et al. (2012) Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models. BMC Med., 10, 80.
36. Boreddy,S.R. et al. (2011) Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway. Clin. Cancer Res., 17, 1784–1795.
37. Kandala,P.K. et al. (2012) Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3). BMC Med., 10, 9.
38. Pramanik,K.C. et al. (2014) CBP-mediated FOXO-1 acetylation inhibits pancreatic tumor growth by targeting SirT. Mol. Cancer Ther., 13, 687–698.
39. Fofaria,N.M. et al. (2014) Critical role of STAT3 in melanoma metastasis through anoikis resistance. Oncotarget, 5, 7051–7064.
40. Cheng,H.L. et al. (2010) Arecoline induces HA22T/VGH hepatoma cells to undergo anoikis - involvement of STAT3 and RhoA activation. Mol. Cancer, 9, 126.
41. Du,X.L. et al. (2009) Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma. Oncogene, 28, 3714–3722.
42. Neiva,K.G. et al. (2009) Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling. Neoplasia, 11, 583–593.
43. Deer,E.L. et al. (2010) Phenotype and genotype of pancreatic cancer cell lines. Pancreas, 39, 425–435.
44. Gysin,S. et al. (2005) Analysis of genomic DNA alterations and mRNA expression patterns in a panel of human pancreatic cancer cell lines. Genes. Chromosomes Cancer, 44, 37–51.